|
|
||||||||



* Department of Microbiology and Immunology and
Division of Rheumatology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232; and
Diabetes Center, University of California, San Francisco, CA 94143
Va14Ja18 natural T (iNKT) cells are innate, immunoregulatory lymphocytes that recognize CD1d-restricted lipid Ags such as
-galactosylceramide (
GalCer). The immunoregulatory functions of iNKT cells are dependent upon either IFN-
or IL-4 production by these cells. We hypothesized that
GalCer presentation by different CD1d-positive cell types elicits distinct iNKT cell functions. In this study we report that dendritic cells (DC) play a critical role in
GalCer-mediated activation of iNKT cells and subsequent transactivation of NK cells. Remarkably, B lymphocytes suppress DC-mediated iNKT and NK cell activation. Nevertheless,
GalCer presentation by B cells elicits low IL-4 responses from iNKT cells. This finding is particularly interesting because we demonstrate that NOD DC are defective in eliciting iNKT cell function, but their B cells preferentially activate this T cell subset to secrete low levels of IL-4. Thus, the differential immune outcome based on the type of APC that displays glycolipid Ags in vivo has implications for the design of therapies that harness the immunoregulatory functions of iNKT cells.
This article has been cited by other articles:
![]() |
L. Bai, Y. Sagiv, Y. Liu, S. Freigang, K. O. A. Yu, L. Teyton, S. A. Porcelli, P. B. Savage, and A. Bendelac Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen {alpha}GalCer PNAS, June 23, 2009; 106(25): 10254 - 10259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, L. Cheng, Z. Wondimu, M. Swain, P. Santamaria, and Y. Yang Cutting Edge: CD28 Engagement Releases Antigen-Activated Invariant NKT Cells from the Inhibitory Effects of PD-1 J. Immunol., June 1, 2009; 182(11): 6644 - 6647. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bialecki, C. Paget, J. Fontaine, M. Capron, F. Trottein, and C. Faveeuw Role of Marginal Zone B Lymphocytes in Invariant NKT Cell Activation J. Immunol., May 15, 2009; 182(10): 6105 - 6113. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lalazar, A. B. Ya'acov, D. M. Livovsky, M. El Haj, O. Pappo, S. Preston, L. Zolotarov, and Y. Ilan {beta}-Glycoglycosphingolipid-Induced Alterations of the STAT Signaling Pathways Are Dependent on CD1d and the Lipid Raft Protein Flotillin-2 Am. J. Pathol., April 1, 2009; 174(4): 1390 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tonti, G. Galli, C. Malzone, S. Abrignani, G. Casorati, and P. Dellabona NKT-cell help to B lymphocytes can occur independently of cognate interaction Blood, January 8, 2009; 113(2): 370 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Barral, J. Eckl-Dorna, N. E. Harwood, C. De Santo, M. Salio, P. Illarionov, G. S. Besra, V. Cerundolo, and F. D. Batista B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo PNAS, June 17, 2008; 105(24): 8345 - 8350. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Lang, T. S. Devera, and M. L. Lang Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production Blood, February 15, 2008; 111(4): 2158 - 2162. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Torres, C. Paget, J. Fontaine, T. Mallevaey, T. Matsuoka, T. Maruyama, S. Narumiya, M. Capron, P. Gosset, C. Faveeuw, et al. Prostaglandin D2 Inhibits the Production of IFN-{gamma} by Invariant NK T Cells: Consequences in the Control of B16 Melanoma J. Immunol., January 15, 2008; 180(2): 783 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chung, H. Qin, C.-Y. Kang, S. Kim, L. W. Kwak, and C. Dong An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity Blood, September 15, 2007; 110(6): 2013 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mallevaey, J. Fontaine, L. Breuilh, C. Paget, A. Castro-Keller, C. Vendeville, M. Capron, M. Leite-de-Moraes, F. Trottein, and C. Faveeuw Invariant and Noninvariant Natural Killer T Cells Exert Opposite Regulatory Functions on the Immune Response during Murine Schistosomiasis Infect. Immun., May 1, 2007; 75(5): 2171 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheng, A. Ueno, S. Cho, J. S. Im, S. Golby, S. Hou, S. A. Porcelli, and Y. Yang Efficient Activation of V{alpha}14 Invariant NKT Cells by Foreign Lipid Antigen Is Associated with Concurrent Dendritic Cell-Specific Self Recognition J. Immunol., March 1, 2007; 178(5): 2755 - 2762. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shimizu, A. Goto, M. Fukui, M. Taniguchi, and S.-i. Fujii Tumor Cells Loaded with {alpha}-Galactosylceramide Induce Innate NKT and NK Cell-Dependent Resistance to Tumor Implantation in Mice J. Immunol., March 1, 2007; 178(5): 2853 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chung, B.-S. Kim, Y.-J. Kim, H.-J. Ko, S.-Y. Ko, D.-H. Kim, and C.-Y. Kang CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity In vivo. Cancer Res., July 1, 2006; 66(13): 6843 - 6850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Lang and A. Glatman-Freedman Do CD1-Restricted T Cells Contribute to Antibody-Mediated Immunity against Mycobacterium tuberculosis? Infect. Immun., February 1, 2006; 74(2): 803 - 809. [Full Text] [PDF] |
||||
![]() |
J. A. Cain, J. A. Smith, J. K. Ondr, B. Wang, and J. D. Katz NKT Cells and IFN-{gamma} Establish the Regulatory Environment for the Control of Diabetogenic T Cells in the Nonobese Diabetic Mouse J. Immunol., February 1, 2006; 176(3): 1645 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Skold, X. Xiong, P. A. Illarionov, G. S. Besra, and S. M. Behar Interplay of Cytokines and Microbial Signals in Regulation of CD1d Expression and NKT Cell Activation J. Immunol., September 15, 2005; 175(6): 3584 - 3593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |